Related Experiment Video
Updated: Jun 6, 2026
06:13
Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
The DASH diet and insulin sensitivity.
Alan L Hinderliter1, Michael A Babyak, Andrew Sherwood
1Department of Medicine, Division of Cardiology, University of North Carolina, Chapel Hill, NC 27599-7075, USA. hinderli@med.unc.edu
Current Hypertension Reports
|November 9, 2010
Summary
The DASH diet lowers blood pressure in overweight individuals. Comprehensive lifestyle changes including diet, weight loss, and exercise are needed for significant improvements in insulin sensitivity.
Area of Science:
- Cardiovascular Health
- Metabolic Syndrome
- Nutritional Science
Background:
- Hypertension is a significant health concern, often linked to metabolic abnormalities like insulin resistance.
- Lifestyle modifications are crucial for managing and preventing high blood pressure.
- The Dietary Approaches to Stop Hypertension (DASH) diet is a recognized dietary pattern for blood pressure management.
Purpose of the Study:
- To review the effects of the DASH diet, weight loss, and exercise on blood pressure and insulin sensitivity.
- To analyze the independent and combined impacts of these lifestyle interventions.
- To focus on recent findings from the ENCORE study regarding these interventions.
Main Methods:
- Review of existing literature and analysis of data from the ENCORE study.
- Examination of the effects of the DASH diet alone and in combination with weight loss and exercise.
- Assessment of changes in blood pressure and insulin sensitivity.
Main Results:
- The DASH diet alone reduced blood pressure in overweight individuals with elevated blood pressure.
- Significant improvements in insulin sensitivity were achieved only when the DASH diet was combined with weight loss and exercise.
- The comprehensive lifestyle modification program showed greater benefits for metabolic health.
Conclusions:
- The DASH diet is effective for lowering blood pressure in overweight individuals.
- A multifaceted lifestyle intervention, including diet, weight loss, and exercise, is superior to diet alone for improving insulin sensitivity.
- Integrated lifestyle changes are essential for managing hypertension and associated metabolic issues.
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...